AcelRx Baffled By Zalviso Trial Request On Opioid Dispensing Problems
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA asked for clinical study before reviewing data AcelRx generated after previous ‘complete response,’ CEO King said.